A more accurate way to scan for tuberculosis (TB) has been developed by UK and US researchers, using positron emission tomography (PET).
The team have developed a new radiotracer, which is taken up by live TB bacteria in the body. Radiotracers are radioactive compounds which give off radiation that can be detected by scanners and turned into a 3D image.
The new radiotracer, called FDT, enables PET scans to be used for the first time to accurately pinpoint when and where the disease is still active in a patient’s lungs.
The researchers have put the new radiotracer through extensive pre-clinical trials with no adverse effects and it is now ready to go into Phase I trials in humans.
Two methods currently exist for TB diagnosis: testing for the TB bacteria in a patient’s spit or a PET scan to look for signs of inflammation in the lung, using the common radiotracer FDG.
However, a spit test can show a negative long before the disease has been fully treated in the lungs, which could result in patients finishing treatment too early.
Scanning for inflammation can be helpful in seeing the extent of the disease, but it is not specific to TB, as inflammation can be caused by other conditions. Inflammation can also persist in the lung after the TB bacteria has been eliminated, leading to treatment continuing longer than necessary.
The new approach developed by the researchers is more specific as it uses a carbohydrate that is only processed by the TB bacteria.
A key advantage of the new approach is that it only requires a hospital to have standard radiation control and PET scanners, which are becoming more widely available throughout the world. The new molecule is created from FDG using a relatively simple process involving enzymes developed by the research team. This means it can be produced without specialist expertise or laboratories and so would be a viable option in low- and middle-income countries with less developed healthcare systems. These countries currently see over 80% of global TB cases and deaths from the disease.
In 2021, 10.6 million people fell ill with TB and 1.6 million people died from the disease, making it the world’s second leading infectious killer after COVID-19.
The group lead said: “Finding an accurate way to identify when TB is still active in the body is not only important for initial diagnosis, but to ensure patients are receiving antibiotics long enough to kill the disease, and no longer.
“The common radiotracer FDG and the enzymes we’ve developed to turn it into FDT can all be sent by post. With a minimum of additional training, this effective diagnostic in essence could be rolled out into most healthcare systems around the world – and most importantly, in the places where this disease is still taking its greatest toll.”
Latest News
How an unstructured protein…
By newseditor
Posted 04 Jul
Precise control of endogeno…
By newseditor
Posted 04 Jul
Microglial TGF-β1 ligand re…
By newseditor
Posted 04 Jul
A distal enhancer regulates…
By newseditor
Posted 04 Jul
Targeting bone marrow adipo…
By newseditor
Posted 03 Jul
Other Top Stories
Using bacteria to creating artificial cells with lifelike functiona…
Read more
How machine learning can accelerate solutions for protein design ch…
Read more
Multilevel cognition development abilities using AI
Read more
How visual information travels from the retina to the midbrain
Read more
Bioprinting-assisted tissue assembly to generate organ substitutes…
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Master corepressor inactiva…
By newseditor
Posted 04 Jul
Adult microglial TGFβ1 is r…
By newseditor
Posted 04 Jul
A distal enhancer of GATA3…
By newseditor
Posted 04 Jul
Targeting adipocyte ESRRA p…
By newseditor
Posted 03 Jul
Stress-induced TDP-43 nucle…
By newseditor
Posted 03 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar